Loading chat...

MT SB211

Bill

Status

Passed

4/16/2025

Primary Sponsor

Cora Neumann

Click for details

Origin

Senate

2025 Regular Session

AI Summary

  • Adds epinephrine nasal spray as an approved medication alongside autoinjectable epinephrine for treating anaphylaxis in Montana public and nonpublic schools

  • Allows students with asthma, severe allergies, or anaphylaxis to possess and self-administer prescribed epinephrine nasal spray at school, school-sponsored activities, and during transit

  • Permits schools to maintain stock supplies of epinephrine nasal spray for emergency administration by school nurses or authorized personnel to any student or nonstudent experiencing anaphylaxis

  • Requires schools stocking epinephrine nasal spray to develop protocols for employee training, medication storage, and follow-up care including 9-1-1 calls

  • Effective immediately upon passage and approval

Legislative Description

Revise emergency use of epinephrine in school setting to include nasal spray

Schools and Education

Last Action

Chapter Number Assigned

4/17/2025

Committee Referrals

Human Services2/13/2025
Public Health, Welfare, and Safety1/27/2025

Full Bill Text

No bill text available